4.6 Article

Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma

期刊

BMC CANCER
卷 20, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12885-020-06934-x

关键词

Cervical squamous cell carcinoma; Serum squamous cell carcinoma antigen; Chemosensitivity; Lymph node metastasis; Prognosis; Neoadjuvant chemotherapy

类别

资金

  1. National Natural Science Foundation of China [81501235]
  2. Shengjing Hospital of China Medical University [MF95]
  3. Natural Science Foundation of Liaoning Province [2018010551-301]

向作者/读者索取更多资源

BackgroundOur aim was to investigate the value of serum squamous cell carcinoma (SCC) antigen levels in predicting chemosensitivity, lymph node metastasis, as well as prognosis in patients with cervical squamous cell carcinoma who received neoadjuvant chemotherapy (NACT).MethodsThis retrospective study enrolled 103 patients with cervical squamous cell carcinoma and then compared the SCC antigen levels between patients who underwent NACT followed by radical surgery (NACT group) and those who underwent radical surgery alone (conventional group), and a correlation analysis between SCC antigen levels and chemosensitivity, lymph node metastasis, or survival time was conducted.ResultsThe SCC antigen levels changed after NACT and were associated with chemosensitivity. Moreover, the optimal cut-off value of the percentage decrease in SCC antigen level after the first chemotherapy (FSCC (%)) was 42.0%, which could be used for assessment of chemosensitivity. The rate of positive lymph nodes in patients with pretreatment SCC antigen levels >= 3.9ng/mL was significantly decreased after NACT. The overall survival (OS) of NACT group was significantly longer than that of conventional group when the pretreatment SCC antigen levels were >= 4.55ng/mL. The OS and progression-free survival rates of patients with SCC antigen levels <2.7ng/mL were longer than those 2.7ng/mL after the first chemotherapy.ConclusionsThe 42.0% of FSCC (%) after NACT is a reliable indicator of chemosensitivity. Pretreatment and posttreatment SCC antigen levels can be used in evaluating the lymph node metastases and prognosis of patients with cervical squamous cell carcinoma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据